Skip to main content
. 2019 Nov 15;6(4):111. doi: 10.3390/medicines6040111

Table 4.

The Naranjo scale questions and weighted scores in our patient.

Yes No Do Not Know Score
1. Are there previous conclusive reports on this reaction? +1 0 0 +1
2. Did the adverse event appear after the suspected drug was administered? +2 −1 0 +2
3. Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered? +1 0 0 +1
4. Did the adverse reaction reappear when the drug was readministered? +2 −1 0 2
5. Are there alternative causes (other than the drug) that could on their own have caused the reaction? −1 +2 0 +2
6. Did the reaction reappear when a placebo was given? −1 +1 0 0
7. Was the drug detected in the blood (or other fluids) in concentrations known to be toxic? +1 0 0 0
8. Was the reaction more severe when the dose was increased, or less severe when the dose was decreased? +1 0 0 1
9. Did the patient have a similar reaction to the same or similar drugs in any previous exposure? +1 0 0 0
10. Was the adverse event confirmed by any objective evidence? +1 0 0 1
Total Score 10